Literature DB >> 490882

Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Hypertension Detection and Follow-up Program Cooperative Group.

.   

Abstract

The Hypertension Detection and Follow-up Program (HDFP), in a community-based, randomized controlled trial involving 10,940 persons with high blood pressure (BP), compared the effects on five-year mortality of a systematic antihypertensive treatment program (Stepped Care [SC]) and referral to community medical therapy (Referred Care [RC]). Participants, recruited by population-based screening of 158,906 people aged 30 to 69 years in 14 communities througout the United States, were randomly assigned to SC or RC groups within each center and by entry diastolic blood pressure (DBP) (90 to 104, 105 to 114, and 115 + mm Hg). Over the five years of the study, more than two thirds of the SC participants continued to receive medication, and more than 50% achieved BP levels within the normotensive range, at or below the HDFP goal for DBP. Controls of BP was consistently better for the SC than for the RC group. Five-year mortality from all causes was 17% lower for the SC group compared to the RC group (6.4 vs 7.7 per 100, P less than .01) and 20% lower for the SC subgroup with entry DBP of 90 to 104 mm Hg compared to the corresponding RC subgroup (5.9 vs 7.4 per 100, P less than .01). These findings of the HDFP indicate that the systematic effective management of hypertension has a great potential for reducing mortality for the large numbers of people with high BP in the population, including those with "mild" hypertension.

Entities:  

Mesh:

Year:  1979        PMID: 490882

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  230 in total

Review 1.  The effects of information framing on the practices of physicians.

Authors:  P McGettigan; K Sly; D O'Connell; S Hill; D Henry
Journal:  J Gen Intern Med       Date:  1999-10       Impact factor: 5.128

2.  Intensive care is not expensive compared with other treatments.

Authors:  M Stockwell
Journal:  BMJ       Date:  1999-08-21

Review 3.  Pathogenesis and pathology of coronary heart disease syndromes.

Authors:  P M Ridker; E M Antman
Journal:  J Thromb Thrombolysis       Date:  1999-10       Impact factor: 2.300

Review 4.  [Reserpine-diuretic combinations in therapy of arterial hypertension. Current considerations].

Authors:  M Siepmann; W Kirch
Journal:  Med Klin (Munich)       Date:  1998-12-15

5.  Cost-effectiveness of community-based strategies for blood pressure control in a low-income developing country: findings from a cluster-randomized, factorial-controlled trial.

Authors:  Tazeen H Jafar; Muhammad Islam; Rasool Bux; Neil Poulter; Juanita Hatcher; Nish Chaturvedi; Shah Ebrahim; Peter Cosgrove
Journal:  Circulation       Date:  2011-09-19       Impact factor: 29.690

Review 6.  Progress in the 1980s and new directions in the 1990s with hypertension management. From the stepped-care approach to the individualised programme in hypertension treatment and control.

Authors:  H Pardell; P Armario; R Hernández
Journal:  Drugs       Date:  1992-01       Impact factor: 9.546

7.  Blood pressure nomograms for school children in Iran.

Authors:  Neamatollah Ataei; Asghar Aghamohammadi; Effat Yousefi; Mostafa Hosseini; Keramat Nourijelyani; Mehdy Tayebi; Gholamhasan Khorasani; Arash Chavoshian; Mohsen Hosseini; Mohammad Yousefi
Journal:  Pediatr Nephrol       Date:  2003-12-18       Impact factor: 3.714

8.  Effects of once daily indapamide and pindolol on blood pressure, plasma aldosterone concentration and plasma renin activity in a general practice setting.

Authors:  J P Chalmers; L M Wing; J J Grygiel; M J West; J R Graham; A J Bune
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

9.  Antihypertensive effects of bisoprolol during once daily administration in patients with essential hypertension. A dose-ranging study with parallel groups.

Authors:  L Weiner; G Frithz
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

10.  Comparison of a lifestyle modification program with propranolol use in the management of diastolic hypertension.

Authors:  E J Pérez-Stable; T J Coates; R B Baron; B S Biró; W W Hauck; K S McHenry; P S Gardiner; D Feigal
Journal:  J Gen Intern Med       Date:  1995-08       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.